MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated
mbs303mbs303cd3cd20t MBS303MBS303, composed of a 2:1 bispecific antibody structure, binds to CD20 with two arms and CD3 molecule with one arm to increase affinity with tumor cells and decrease the off-target toxicity